Using an immunofluorescence procedure that allows the simultaneous labeling of tissue for two different antigens, substance P-like immunoreactivity (SPLI) and dynorphin-like immunoreactivity (DLI) were observed to co-occur extensively in striatal neurons of the avian and reptilian basal ganglia and in fibers and terminals in the projection targets of the avian and reptilian striata. Thus, SPLI and DLI apparently co-occur extensively in striatopallidal and striatonigral projection neurons of the avian and reptilian basal ganglia. Since basal ganglia organization is fundamentally similar among amniotes, the present results suggest that SPLI and DLI may also cooccur extensively in striatal neurons in mammals.
In birds, reptiles and mammals, a neuropeptide highly similar or identical to substance P (SP) is present in striatopallidal and striatonigral projection neurons 4"14"18"22"24-26. These SP-containing striatal neurons appear to represent a distinct subpopulation of the medium-sized neurons that make up the vast majority of the striatal neurons present in the basal ganglia <1°'22"25. Several recent studies have shown that members of the dynorphin family of peptides also appear to be present in striatopallidal and striatonigral projection neurons in the basal ganglia of birds, reptiles and mammals 2° 23,27,28. The present studies in White Carneaux pigeons and red-eared turtles were carried out to determine whether the dynorphinergic striatal neurons represent a neuronal population that is distinct from the population of SP-containing striatal neurons or whether dynorphin and SP are contained in the same striatal neurons.
An immunofluorescence double-labeling procedure was used that allows two different tissue antigens to be simultaneously and differentially labeled with two different fluorophores s'19'24'3°. This doublelabeling procedure, which has been referred to as the simultaneous immunofluorescence procedure, has been described previously in greater detail 8"24. In the present study, SP-containing neurons and fibers were labeled using a rat monoclonal antibody (Accurate Chemical and Scientific Corporation) in conjunction with a tetramethylrhodamine isothiocyanate (TRITC)-conjugated secondary antiserum (goat anti-rat IgG), while dynorphinergic neurons and fibers were labeled using a rabbit antiserum against Dynorphin Al_17 (generously provided by L. Terenius of Uppsala University, Sweden) in conjunction with a fluorescein isothiocyanate (FITC)-conjugated secondary antiserum (goat anti-rabbit lgG). Animals received intraventricular injections of colchicine (100/~g in pigeons and 50/,g in turtles) to enhance perikaryal immunoreactivity. Following a postinjection survival time of 36-48 h (pigeons) or 96-12(I (turtles), the animals were deeply anesthetized (ketamine for turtles and 35% chloral hydrate for pigeons) and their brains fixed by transcardial perfusion as described previously 24-2~'. The brains were then sectioned frozen at 40/~m and processed according to the simultaneous immunofluorescence procedure 8"24. Tissue incubations were carried out by first incubating tissue in a primary antisera cocktail containing the anti-SP antibody (at a 1:1000 dilution) and the anti-Dynorphin Al_I7 antiserum (at a 1:250
